Skip to main content
Clinical Trials/TCTR20230131002
TCTR20230131002
Completed
Phase 2

Effect of Time-Restricted Eating 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obese with diabetic patients: A prospective randomized controlled trial

This research was funded by Endocrine Society of Thailand0 sites99 target enrollmentJanuary 31, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Time-restricted eating in 108 T2DM obese participants, in both sexes, aged 30-60 years, living in Northern Thailand
Sponsor
This research was funded by Endocrine Society of Thailand
Enrollment
99
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 31, 2023
End Date
September 1, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
This research was funded by Endocrine Society of Thailand

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria: BMI more than or equal 25 kg/m2
  • age 30 \- 60 years old
  • and diagnosed DM by using ADA criteria

Exclusion Criteria

  • The exclusion criteria excluded any of the followings such as a history of steroids used, hormonal drugs or weight loss pill used within 3 months, pregnancy or plan to become pregnant, history of cancer, HIV, active pulmonary TB, Hepatitis B or C, was admitted within 3 months, previous history of severe hypoglycemia within six months, bed\-ridden, history of swallowing problem, GI surgery e.g. bariatric surgery, taking insulin injections in current treatment, glipizide dose \> 15 mg/day, start taking SGLT2 or GLP\-1 RA within one month, CKD stage IIIB\-V, acute myocardial infarction or acute stroke within six months.

Outcomes

Primary Outcomes

Not specified

Similar Trials